ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Venlafaxin Stada retard 150, Hartkapseln, retardiert - 14
60134020 Spirig HealthCare AG
Venlafaxin Stada retard 150, Hartkapseln, retardiert23.10.2009
  23.10.2009
Venlafaxine (N06AX16) 
WHO-DDD 
01.06.14
01.06. 
B  
No 
IPCI
PR  
k.A.PR
  
7680601340205Synthetika
  
Composition
venlafaxinum 150 mg ut venlafaxini hydrochloridum, sacchari sphaerae corresp. saccharum 161.94 mg, hydroxypropylcellulosum, hypromellosum, talcum, ethylcellulosum, ammoniae solutio 28 per centum, dibutylis sebacas, acidum oleicum, silica colloidalis anhydrica, Kapselhülle: gelatina, natrii laurilsulfas corresp. natrium 6 µg, E 104, E 110 16.9 µg, E 131, E 171, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Venlafaxine150 mg
BAG: Active AgentDose
Venlafaxine150 mg
 
Inactive agentsDoseadditional_information
Acidum Oleicum  
Ammoniae Solutio28  
Dibutylis Sebacas  
E 104 color.
E 11016.9 µgcolor.
E 131 color.
E 171 color.
Ethylcellulosum  
Gelatina Kapselhülle
Hydroxypropylcellulosum  
Hypromellosum  
Natrii Laurilsulfas  
Per Centum  
Pro Capsula  
Sacchari Sphaerae  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 12.05.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home